Seventy per cent fewer HIV infections seen with PrEP injections, compared with pills, in gay/bi men and trans women
PrEP implant could last well over a year
Removable PrEP implant produces high drug levels in rabbits; further studies planned
Going local – prevention conference hears about rings, douches, and soluble suppositories
Beyond Truvada – what is the future of PrEP?
The long tail of injectable PrEP is especially long for women
Long-acting injectable ARVs are convenient and private, study participants report
Many gay/bisexual men currently taking PrEP would switch to injectable forms of the therapy should it become available
Long-acting cabotegravir injection shows promise for HIV prevention
